Hospital Pediátrico de Coimbra (ULS de Coimbra – Principal Investigator Dr. Catarina Neves) has enrolled the first national participant in the EMPA-KIDNEY Kids study. The EMPA-KIDNEY Kids study aims to assess the pharmacokinetics, safety, and efficacy of empagliflozin tablets in children and adolescents aged 2 to 17 years with chronic kidney disease. Study details are...Continue Reading
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA
